170 related articles for article (PubMed ID: 17186378)
1. Estrogen-dependent growth and estrogen receptor (ER)-alpha concentration in T47D breast cancer cells are inhibited by VACM-1, a cul 5 gene.
Johnson AE; Le IP; Buchwalter A; Burnatowska-Hledin MA
Mol Cell Biochem; 2007 Jul; 301(1-2):13-20. PubMed ID: 17186378
[TBL] [Abstract][Full Text] [Related]
2. T47D breast cancer cell growth is inhibited by expression of VACM-1, a cul-5 gene.
Burnatowska-Hledin MA; Kossoris JB; Van Dort CJ; Shearer RL; Zhao P; Murrey DA; Abbott JL; Kan CE; Barney CC
Biochem Biophys Res Commun; 2004 Jul; 319(3):817-25. PubMed ID: 15184056
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol enhances anti-proliferative effect of VACM-1/cul5 in T47D cancer cells.
Lubbers J; Lewis S; Harper E; Hledin MP; Marquez GA; Johnson AE; Graves DR; Burnatowska-Hledin MA
Cell Biol Toxicol; 2011 Apr; 27(2):95-105. PubMed ID: 20949323
[TBL] [Abstract][Full Text] [Related]
4. Expression of VACM-1/cul5 mutant in endothelial cells induces MAPK phosphorylation and maspin degradation and converts cells to the angiogenic phenotype.
Buchwalter A; Van Dort C; Schultz S; Smith R; Le IP; Abbott JL; Oosterhouse E; Johnson AE; Hansen-Smith F; Burnatowska-Hledin M
Microvasc Res; 2008 Mar; 75(2):155-68. PubMed ID: 17950367
[TBL] [Abstract][Full Text] [Related]
5. Truncated form of VACM-1/cul-5 with an extended 3' untranslated region stimulates cell growth via a MAPK-dependent pathway.
Sartor A; Kossoris JB; Wilcox R; Shearer R; Zeneberg AE; Zhao P; Lazdins I; Burnatowska-Hledin MA
Biochem Biophys Res Commun; 2006 May; 343(4):1086-93. PubMed ID: 16581022
[TBL] [Abstract][Full Text] [Related]
6. VACM-1, a cul-5 gene, inhibits cellular growth by a mechanism that involves MAPK and p53 signaling pathways.
Van Dort C; Zhao P; Parmelee K; Capps B; Poel A; Listenberger L; Kossoris J; Wasilevich B; Murrey D; Clare P; Burnatowska-Hledin M
Am J Physiol Cell Physiol; 2003 Dec; 285(6):C1386-96. PubMed ID: 12917106
[TBL] [Abstract][Full Text] [Related]
7. Estrogen activation of the mitogen-activated protein kinase is mediated by ER-α36 in ER-positive breast cancer cells.
Zhang X; Deng H; Wang ZY
J Steroid Biochem Mol Biol; 2014 Sep; 143():434-43. PubMed ID: 24973581
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of VACM-1/Cul5 by protein kinase A regulates its neddylation and antiproliferative effect.
Bradley SE; Johnson AE; Le IP; Oosterhouse E; Hledin MP; Marquez GA; Burnatowska-Hledin M
J Biol Chem; 2010 Feb; 285(7):4883-95. PubMed ID: 19917606
[TBL] [Abstract][Full Text] [Related]
9. Aquaporin-2 levels in vitro and in vivo are regulated by VACM-1, a cul 5 gene.
Le IP; Schultz S; Andresen BT; Dewey GL; Zhao P; Listenberger L; Deen PM; Buchwalter A; Barney CC; Burnatowska-Hledin MA
Cell Physiol Biochem; 2012; 30(5):1148-58. PubMed ID: 23171819
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of VACM-1/cul5 exons in cancer cell lines.
Lewis SP; Willis AN; Johnson AE; Resau J; Burnatowska-Hledin MA
APMIS; 2011 Jul; 119(7):421-30. PubMed ID: 21635549
[TBL] [Abstract][Full Text] [Related]
11. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
12. Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.
Vladusic EA; Hornby AE; Guerra-Vladusic FK; Lakins J; Lupu R
Oncol Rep; 2000; 7(1):157-67. PubMed ID: 10601611
[TBL] [Abstract][Full Text] [Related]
13. Nuclear localization signal sequence is required for VACM-1/CUL5-dependent regulation of cellular growth.
Willis AN; Dean SE; Habbouche JA; Kempers BT; Ludwig ML; Sayfie AD; Lewis SP; Harrier S; DeBruine ZJ; Garrett R; Burnatowska-Hledin MA
Cell Tissue Res; 2017 Apr; 368(1):105-114. PubMed ID: 27834018
[TBL] [Abstract][Full Text] [Related]
14. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
[TBL] [Abstract][Full Text] [Related]
15. ER-α36 mediates estrogen-stimulated MAPK/ERK activation and regulates migration, invasion, proliferation in cervical cancer cells.
Sun Q; Liang Y; Zhang T; Wang K; Yang X
Biochem Biophys Res Commun; 2017 Jun; 487(3):625-632. PubMed ID: 28435071
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
Pietras RJ; Márquez DC; Chen HW; Tsai E; Weinberg O; Fishbein M
Steroids; 2005; 70(5-7):372-81. PubMed ID: 15862820
[TBL] [Abstract][Full Text] [Related]
17. VACM-1, a cullin gene family member, regulates cellular signaling.
Burnatowska-Hledin M; Zhao P; Capps B; Poel A; Parmelee K; Mungall C; Sharangpani A; Listenberger L
Am J Physiol Cell Physiol; 2000 Jul; 279(1):C266-73. PubMed ID: 10898738
[TBL] [Abstract][Full Text] [Related]
18. Estrogen regulates JNK1 genomic localization to control gene expression and cell growth in breast cancer cells.
Sun M; Isaacs GD; Hah N; Heldring N; Fogarty EA; Kraus WL
Mol Endocrinol; 2012 May; 26(5):736-47. PubMed ID: 22446103
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
Al-Dhaheri MH; Rowan BG
Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
[TBL] [Abstract][Full Text] [Related]
20. Involvement of ER-α36, Src, EGFR and STAT5 in the biphasic estrogen signaling of ER-negative breast cancer cells.
Zhang XT; Ding L; Kang LG; Wang ZY
Oncol Rep; 2012 Jun; 27(6):2057-65. PubMed ID: 22426783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
